MD Farma Closes Series A Funding and Changes Name to Corganics as the Company Expands Clinical Cannabinoid (CBD) Product Lines Sold Only in Healthcare Facilities
Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company have led a USD 156m Series B funding round for biotechnology business Quell Therapeutics.
Recent Comments